| Polyethylene Glycol Conjugated Polymeric Nanocapsules for Targeted Delivery of Quercetin to Folate-Expressing Cancer Cells in Vitro and in Vivo RI El-Gogary, N Rubio, JTW Wang, WT Al-Jamal, M Bourgognon, H Kafa, ... ACS nano 8 (2), 1384-1401, 2014 | 184 | 2014 |
| Brain delivery of olanzapine by intranasal administration of transfersomal vesicles HA Salama, AA Mahmoud, AO Kamel, M Abdel Hady, GAS Awad Journal of liposome research 22 (4), 336-345, 2012 | 150 | 2012 |
| Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route YM Gabal, AO Kamel, OA Sammour, AH Elshafeey International journal of pharmaceutics 473 (1-2), 442-457, 2014 | 142 | 2014 |
| Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studies S Salah, AA Mahmoud, AO Kamel Drug delivery 24 (1), 846-856, 2017 | 137 | 2017 |
| Phospholipid based colloidal poloxamer–nanocubic vesicles for brain targeting via the nasal route HA Salama, AA Mahmoud, AO Kamel, MA Hady, GAS Awad Colloids and surfaces B: biointerfaces 100, 146-154, 2012 | 125 | 2012 |
| Stealth lipid polymer hybrid nanoparticles loaded with rutin for effective brain delivery–comparative study with the gold standard (Tween 80): optimization, characterization … RAH Ishak, NM Mostafa, AO Kamel Drug delivery 24 (1), 1874-1890, 2017 | 85 | 2017 |
| Interactions between DNA and Gemini surfactant: impact on gene therapy: part I T Ahmed, AO Kamel, SD Wettig Nanomedicine 11 (3), 289-306, 2016 | 83 | 2016 |
| Design of cationic nanostructured heterolipid matrices for ocular delivery of methazolamide J Youshia, AO Kamel, A El Shamy, S Mansour International journal of nanomedicine, 2483-2496, 2012 | 68 | 2012 |
| Preparation of intravenous stealthy acyclovir nanoparticles with increased mean residence time AO Kamel, GAS Awad, AS Geneidi, ND Mortada Aaps Pharmscitech 10, 1427-1436, 2009 | 60 | 2009 |
| Injectable long acting chitosan/tripolyphosphate microspheres for the intra-articular delivery of lornoxicam: Optimization and in vivo evaluation H Abd-Allah, AO Kamel, OA Sammour Carbohydrate polymers 149, 263-273, 2016 | 54 | 2016 |
| Utility of Nanosized Microemulsion for Transdermal Delivery of Tolterodine Tartrate: Ex-Vivo Permeation and In-Vivo Pharmacokinetic Studies AH Elshafeey, AO Kamel, MM Fathallah Pharmaceutical research 26, 2446-2453, 2009 | 54 | 2009 |
| Anticancer effect of atorvastatin nanostructured polymeric micelles based on stearyl-grafted chitosan GM Mekhail, AO Kamel, GAS Awad, ND Mortada International journal of biological macromolecules 51 (4), 351-363, 2012 | 53 | 2012 |
| Enhancement of human oral bioavailability and in vitro antitumor activity of rosuvastatin via spray dried self-nanoemulsifying drug delivery system AO Kamel, AA Mahmoud Journal of biomedical nanotechnology 9 (1), 26-39, 2013 | 49 | 2013 |
| Doxycycline hydrochloride-metronidazole solid lipid microparticles gels for treatment of periodontitis: Development, in-vitro and in-vivo clinical evaluation HA Gad, AO Kamel, OM Ezzat, HF El Dessouky, OA Sammour Expert opinion on drug delivery 14 (11), 1241-1251, 2017 | 41 | 2017 |
| Terbinafine hydrochloride nanovesicular gel: In vitro characterization, ex vivo permeation and clinical investigation SM AbdelSamie, AO Kamel, OA Sammour, SM Ibrahim European Journal of Pharmaceutical Sciences 88, 91-100, 2016 | 39 | 2016 |
| Functionalized chitosan nanoparticles for cutaneous delivery of a skin whitening agent: an approach to clinically augment the therapeutic efficacy for melasma treatment S Hatem, SA Elkheshen, AO Kamel, M Nasr, NH Moftah, MH Ragai, ... Drug Delivery 29 (1), 1212-1231, 2022 | 38 | 2022 |
| Use of biorelevant media for assessment of a poorly soluble weakly basic drug in the form of liquisolid compacts: in vitro and in vivo study MA Badawy, AO Kamel, OA Sammour Drug delivery 23 (3), 808-817, 2016 | 37 | 2016 |
| Ammonium methacrylate units polymer content and their effect on acyclovir colloidal nanoparticles properties and bioavailability in human volunteers AH Elshafeey, AO Kamel, GAS Awad Colloids and Surfaces B: Biointerfaces 75 (2), 398-404, 2010 | 36 | 2010 |
| Background and different treatment modalities for melasma: Conventional and nanotechnology-based approaches S Hatem, NM El Hoffy, RS Elezaby, M Nasr, AO Kamel, SA Elkheshen Journal of drug delivery science and technology 60, 101984, 2020 | 33 | 2020 |
| Synthesis and evaluation of alendronate-modified gelatin biopolymer as a novel osteotropic nanocarrier for gene therapy GM Mekhail, AO Kamel, GAS Awad, ND Mortada, RL Rodrigo, ... Nanomedicine 11 (17), 2251-2273, 2016 | 28 | 2016 |
